UNLABELLED: Kruppel-like factor 6 (KLF6), a zinc finger transcription factor and tumor suppressor, is induced as an immediate-early gene during hepatic stellate cell (HSC) activation. The paradoxical induction of a tumor suppressor in HSCs during proliferation led us to explore the biology of wildtype KLF6 (KLF6(WT) ) and its antagonistic, alternatively spliced isoform KLF6(SV1) in cultured HSCs and animal models. The animal models generated include a global heterozygous KLF6 mouse (Klf6+/-), and transgenic mice expressing either hKLF6(WT) or hKLF6(SV1) under the control of the Collagen α2 (I) promoter to drive HSC-specific gene expression following injury. The rat Klf6 transcript has multiple splice forms that are homologous to those of the human KLF6 gene. Following a transient increase, all rat Klf6 isoforms decreased in response to acute carbon tetrachloride (CCl(4)) liver injury and culture-induced activation. After acute CCl(4), Klf6+/- mice developed significantly increased fibrosis and enhanced fibrogenic messenger RNA (mRNA) and protein expression. In contrast, HSC-specific transgenic mice overexpressing KLF6(WT) or KLF6(SV1) developed significantly diminished fibrosis with reduced expression of fibrogenic genes. Chromatin IP and quantitative reverse-transcription polymerase chain reaction in mouse HSCs overexpressing KLF6(WT) demonstrated KLF6(WT) binding to GC boxes in promoters of Colα1 (I), Colα2 (I), and beta-platelet-derived growth factor receptor (β-Pdgfr) with reduced gene expression, consistent with transcriptional repression by KLF6. Stellate cells overexpressing either KLF6(WT) or KLF6(SV1) were more susceptible to apoptotic stress based on poly (ADP-ribose) polymerase (PARP) cleavage. CONCLUSION: KLF6 reduces fibrogenic activity of HSCs by way of two distinct mechanisms, direct transcriptional repression of target fibrogenic genes and increased apoptosis of activated HSCs. These results suggest that following its initial induction, sustained down-regulation of KLF6 in liver injury may allow de-repression of fibrogenic genes and decreased stellate cell clearance by inhibiting apoptosis.
UNLABELLED: Kruppel-like factor 6 (KLF6), a zinc finger transcription factor and tumor suppressor, is induced as an immediate-early gene during hepatic stellate cell (HSC) activation. The paradoxical induction of a tumor suppressor in HSCs during proliferation led us to explore the biology of wildtype KLF6 (KLF6(WT) ) and its antagonistic, alternatively spliced isoform KLF6(SV1) in cultured HSCs and animal models. The animal models generated include a global heterozygous KLF6mouse (Klf6+/-), and transgenic mice expressing either hKLF6(WT) or hKLF6(SV1) under the control of the Collagen α2 (I) promoter to drive HSC-specific gene expression following injury. The ratKlf6 transcript has multiple splice forms that are homologous to those of the humanKLF6 gene. Following a transient increase, all ratKlf6 isoforms decreased in response to acute carbon tetrachloride (CCl(4)) liver injury and culture-induced activation. After acute CCl(4), Klf6+/- mice developed significantly increased fibrosis and enhanced fibrogenic messenger RNA (mRNA) and protein expression. In contrast, HSC-specific transgenic mice overexpressing KLF6(WT) or KLF6(SV1) developed significantly diminished fibrosis with reduced expression of fibrogenic genes. Chromatin IP and quantitative reverse-transcription polymerase chain reaction in mouse HSCs overexpressing KLF6(WT) demonstrated KLF6(WT) binding to GC boxes in promoters of Colα1 (I), Colα2 (I), and beta-platelet-derived growth factor receptor (β-Pdgfr) with reduced gene expression, consistent with transcriptional repression by KLF6. Stellate cells overexpressing either KLF6(WT) or KLF6(SV1) were more susceptible to apoptotic stress based on poly (ADP-ribose) polymerase (PARP) cleavage. CONCLUSION:KLF6 reduces fibrogenic activity of HSCs by way of two distinct mechanisms, direct transcriptional repression of target fibrogenic genes and increased apoptosis of activated HSCs. These results suggest that following its initial induction, sustained down-regulation of KLF6 in liver injury may allow de-repression of fibrogenic genes and decreased stellate cell clearance by inhibiting apoptosis.
Authors: Mario R Calderon; Mark Verway; Beum-Soo An; Analisa DiFeo; Tarek A Bismar; David K Ann; John A Martignetti; Tali Shalom-Barak; John H White Journal: J Biol Chem Date: 2012-01-25 Impact factor: 5.157
Authors: G Narla; K E Heath; H L Reeves; D Li; L E Giono; A C Kimmelman; M J Glucksman; J Narla; F J Eng; A M Chan; A C Ferrari; J A Martignetti; S L Friedman Journal: Science Date: 2001-12-21 Impact factor: 47.728
Authors: Goutham Narla; Analisa DiFeo; Shen Yao; Asoka Banno; Eldad Hod; Helen L Reeves; Rui F Qiao; Olga Camacho-Vanegas; Alice Levine; Alexander Kirschenbaum; Andrew M Chan; Scott L Friedman; John A Martignetti Journal: Cancer Res Date: 2005-07-01 Impact factor: 12.701
Authors: Goutham Narla; Analisa Difeo; Helen L Reeves; Daniel J Schaid; Jennifer Hirshfeld; Eldad Hod; Amanda Katz; William B Isaacs; Scott Hebbring; Akira Komiya; Shannon K McDonnell; Kathleen E Wiley; Steven J Jacobsen; Sarah D Isaacs; Patrick C Walsh; S Lilly Zheng; Bao-Li Chang; Danielle M Friedrichsen; Janet L Stanford; Elaine A Ostrander; Arul M Chinnaiyan; Mark A Rubin; Jianfeng Xu; Stephen N Thibodeau; Scott L Friedman; John A Martignetti Journal: Cancer Res Date: 2005-02-15 Impact factor: 12.701
Authors: Ewa Wandzioch; Asa Kolterud; Maria Jacobsson; Scott L Friedman; Leif Carlsson Journal: Proc Natl Acad Sci U S A Date: 2004-11-09 Impact factor: 11.205
Authors: Sigal Kremer-Tal; Helen L Reeves; Goutham Narla; Swan N Thung; Myron Schwartz; Analisa Difeo; Amanda Katz; Jordi Bruix; Paulette Bioulac-Sage; John A Martignetti; Scott L Friedman Journal: Hepatology Date: 2004-11 Impact factor: 17.425
Authors: V Ratziu; A Lalazar; L Wong; Q Dang; C Collins; E Shaulian; S Jensen; S L Friedman Journal: Proc Natl Acad Sci U S A Date: 1998-08-04 Impact factor: 11.205
Authors: Y Inagaki; S Truter; G Bou-Gharios; L A Garrett; B de Crombrugghe; T Nemoto; P Greenwel Journal: Biochem Biophys Res Commun Date: 1998-09-29 Impact factor: 3.575
Authors: Brian P Hermann; Keren Cheng; Anukriti Singh; Lorena Roa-De La Cruz; Kazadi N Mutoji; I-Chung Chen; Heidi Gildersleeve; Jake D Lehle; Max Mayo; Birgit Westernströer; Nathan C Law; Melissa J Oatley; Ellen K Velte; Bryan A Niedenberger; Danielle Fritze; Sherman Silber; Christopher B Geyer; Jon M Oatley; John R McCarrey Journal: Cell Rep Date: 2018-11-06 Impact factor: 9.423
Authors: Xi Qiao; Padmashree Rao; Yun Zhang; Lixin Liu; Min Pang; Hailong Wang; Min Hu; Xinrui Tian; Jianlin Zhang; Ye Zhao; Xin Maggie Wang; Chengshi Wang; Hong Yu; Fei Guo; Qi Cao; Yiping Wang; Yuan Min Wang; Geoff Yu Zhang; Vincent W Lee; Stephen I Alexander; Guoping Zheng; David C H Harris Journal: J Am Soc Nephrol Date: 2017-11-27 Impact factor: 10.121
Authors: Tsukasa Nabekura; Luke Riggan; Andrew D Hildreth; Timothy E O'Sullivan; Akira Shibuya Journal: Immunity Date: 2019-12-03 Impact factor: 31.745
Authors: Cheri L Lamb; Giovan N Cholico; Xinzhu Pu; Gerald D Hagler; Kenneth A Cornell; Kristen A Mitchell Journal: Toxicol Appl Pharmacol Date: 2016-09-28 Impact factor: 4.219
Authors: Maria Ruart; Laia Chavarria; Genís Campreciós; Nuria Suárez-Herrera; Carla Montironi; Sergi Guixé-Muntet; Jaume Bosch; Scott L Friedman; Juan Carlos Garcia-Pagán; Virginia Hernández-Gea Journal: J Hepatol Date: 2018-10-25 Impact factor: 25.083